2nd Nov 2007 14:55
Skyepharma PLC02 November 2007 For Immediate Release 2 November 2007 SkyePharma PLC ("the Company") The Company was informed on 1st November 2007 that as a result of transactionson 1st November 2007 by the SkyePharma PLC Share Purchase Plan (an approved allemployee share purchase plan) the Trustees of the Plan purchased an additional7,240 Ordinary Shares of the Company at a price of 15.75 pence per share. Following these transactions, the Trustees hold on behalf of the Plan, a totalof 139,439 Ordinary Shares representing 0.017% of the share capital of theCompany. The class of discretionary beneficiaries for whom the Trustees holdsuch shares consists of employees of the Company, including the followingExecutive Directors: Frank Condella and Peter Grant. As a result of these transactions, the following Executive Directors have thefollowing additional interests as a result of their personal participation inthe Plan:- Partnership Shares Matching Shares Total number of purchased on 1 awarded on 1 Partnership and November 2007 at November 2007 Matching Shares 15.75p per share at 15.75p per held on 1 share November 2007 Frank Condella 794 794 19,236Peter Grant 794 794 11,864 In accordance with the rules of the Plan these Directors have been awardedMatching Shares on the basis of one Matching Share (Ordinary Share) for eachPartnership Share (Ordinary Share). The beneficial ownership of the Matching Shares will pass to the Directors inthree years' time subject to continued employment and the retention of theunderlying Partnership Shares. The execution of the transaction noted above did not involve any of theCompany's Directors or any persons discharging managerial responsibility. This notification relates to transactions notified in accordance with Disclosureand Transparency Rule 3.1.4R(1)(a). This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L